Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Formosa-AimMax’s post-surgery eye care treatment
In two Phase III trials, the ophthalmic suspension demonstrated quick and lasting clearance of inflammation and pain relief. Credit: Marina Vitale on Unsplash.
In two Phase III trials, the ophthalmic suspension demonstrated quick and lasting clearance of inflammation and pain relief. Credit: Marina Vitale on Unsplash.